Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-25-000095
Filing Date
2025-02-19
Accepted
2025-02-19 16:36:42
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740000996.html 4  
1 FORM 4 wk-form4_1740000996.xml 4 4674
  Complete submission text file 0000875320-25-000095.txt   6102
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Tatsis Ourania (Reporting) CIK: 0001789815 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 25640839